APEX1 and cancer: This process may fulfill the cancer cells’ requirement for a high amount of APE1 to counteract the DNA damage inferred by drugs in a paracrine manner, suggesting that APE1-secretion could represent a novel damage-associated molecular pattern (DAMP) mechanism that deserves further in-depth study to develop inhibitors that could specifically target alterations of APE1 secretion in different cancers.